Table 2. Multiple stepwise linear regression analysis of PFS-HR and the odds ratio for overall response.
PFS-HR | Odds ratio for overall response | ||||
---|---|---|---|---|---|
Factor | Regression coefficient (95% CI) | P | Regression coefficient (95% CI) | P | |
Trial design (molecularly-selected vs. all-comer) | −0.42 (−0.67 to −0.18) | < 0.01 | 4.46 (2.52–6.39) | < 0.01 | |
Primary endpoint (PFS vs. other) | −0.31 (−0.56 to −0.53) | 0.02 | excluded | ||
Line of treatment (1st vs. other) | Excluded | excluded | |||
Year of trial initiation (before or in 2006 vs. 2007 or later)† | Excluded | excluded | |||
No. of randomized patients | Excluded | excluded | |||
Type of reporting (full text vs. abstract only) | Excluded | excluded |
The threshold p values for entry into and removal from the model were 0.05 and 0.20, respectively.
†The cutoff level was set as the median year of trial initiation. PFS-HR, progression-free survival-hazard ratio; CI, confidence interval.